The Sheffield Institute for Translational Neuroscience (SITraN) is unlike any other in the world. Explore over a decade of advances in neuroscience that have had, and continue to have, a positive impact on the lives of patients and their families.
10 years of impact
Professor Dame Pamela Shaw, Director of SITraN, and Professor Koen Lamberts, President and Vice-Chancellor of the University of Sheffield, tell us about the last decade of progress.
Patient model systems of neurodegenerative diseases
Researchers at SITraN are developing models of cells in the nervous system using patient skin cells. And they’re using these models to find new potential treatments.
State-of-the-art drug screens for neurodegenerative diseases
What if a drug already being safely used by the population could also help treat a different, unrelated disease? With thousands of drugs available, and more being developed in labs across the globe, drug screening is vital to make sure potential treatments for diseases are not being missed.
Enhancing MND patients' quality of life
Every year motor neuron disease (MND) claims the independence of over 2,000 people in the UK. Researchers from the Sheffield Institute for Translational Neuroscience (SITraN) are working to enhance patient quality of life while we wait for disease-modifying therapies to come through.
A turning point for motor neurone disease
An investigational drug has shown promising signs of slowing the progression of a type of motor neurone disease.
Detecting and slowing the progress of dementia
Scientists at SITraN are striving to find ways to detect dementia much earlier and investigating potential treatments to slow the progress of the disease.
Precision medicine for Parkinson’s Disease
By gaining a better understanding of Parkinson's disease, we are working towards potential neuroprotective treatments which could slow down the progression of the disease.